d. dobi, zs . bodó, É. kemény, k. boda a , p. szenohradszky b , e. szederkényi b , b....

20
Kidney allografts with biopsy features of chronic mixed rejection reflect poorer survival than those with pure chronic antibody- mediated rejection D. Dobi, Zs. Bodó, É. Kemény, K. Boda a , P. Szenohradszky b , E. Szederkényi b , B. Iványi Departments of Pathology, Medical Physics and Informatics a and Surgery b University of Szeged, Szeged, Hungary

Upload: coty

Post on 24-Feb-2016

18 views

Category:

Documents


0 download

DESCRIPTION

Kidney allografts with biopsy features of chronic mixed rejection reflect poorer survival than those with pure chronic antibody-mediated rejection. D. Dobi, Zs . Bodó, É. Kemény, K. Boda a , P. Szenohradszky b , E. Szederkényi b , B. Iványi - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Kidney allografts with biopsy features of chronic mixed rejection reflect

poorer survival than those with pure chronic antibody-mediated rejection

D. Dobi, Zs. Bodó, É. Kemény, K. Bodaa, P. Szenohradszkyb, E. Szederkényib, B. Iványi

Departments of Pathology, Medical Physics and Informaticsa and Surgeryb

University of Szeged, Szeged, Hungary

Page 2: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Introduction

In late dysfunctional kidney allograft biopsies

three rejection phenotypes can be observed:

• chronic antibody-mediated rejection (AMR)

• acute T-cell-mediated rejection (TMR)

• chronic active TMR

Page 3: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

ptcmlcg

Chronic AMR: transplant glomerulopathy and/or transplant capillaropathy

Page 4: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Acute TMR: interstitial infiltrates and tubulitis (interstitial rejection, ISR) with or without intimal arteritis

Page 5: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Chronic active TMR: mononuclears in intimal fibrosis (cvmo)

Page 6: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

• Frequency: chronic AMR > acute TMR; chronic active TMR is exceptional

• Chronic AMR and TMR may concur, termed chronic mixed rejection (CMR)

Page 7: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Objectives

To analyze

• the histological patterns of chronic mixed rejection (CMR)

• the clinicopathological relevance of the different patterns of CMR

Page 8: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Material and methods

• From 2001 to 2011, 61 biopsies displayed the histological features of chronic AMR (cg and/or ptcml ± C4d-positivity)

• Luminex data were not avaible

• Re-evaluation according to the Banff scheme (v, g, i, t, ptc, cg, ci,ct, ah) plus

• Scoring of chronic arterial changes: mononuclears in

intimal fibrosis (cvmo), intimal fibrosis (cvIF), intimal

fibroelastosis (cvIFE); and tubular HLA-DR and ptcml

Page 9: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

• Staining of chronic active arteritis (cvmo) cases

with CD3 and CD68 in adjacent sections

• Two groups for clinicopathological analysis:

purely CAMR vs CMR

• Statistics: Spearman’s correlation, hierarchical

cluster analysis, Kaplan-Meier estimator, Cox

regression

Page 10: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Results: main clinical data

 All

patients (n=61)

Purely CAMR (n=35)

CMR (n=26) p

Posttransplant time (months) 66±49 70±49 60±49 ns

eGFR (ml/min/1.73 m2) 26±12 28±12 23±13 ns

Postbiopsy follow-up (months) 23±22 26±22 19±20 ns

Page 11: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Chronic active TMR Chronic active TMR and acute ISR

Acute ISR

Purely CAMR CMR

35

12

4

10

Histological patterns

Page 12: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Features of chronic active arteritis

Severe luminal narrowing (median score 3),

mononuclears scattered throughout the fibrotic intima,

T-cell predominance

PAS

CD3

CD68

Page 13: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Significant (p<0.05) and positive Spearman correlation coefficients between Banff scores and chronic arterial changes

t HLA-DR cvmo ptc C4d g cg ptcml cvIF ci ct ah cvIFE

i 0.769 0.606 0.347 0.301 0.264t 0.654 0.2750.354

HLA-DR 0.363cvmo

ptc 0.3280.331C4d 0.303

g 0.338cg 0.258

ptcml 0.414 0.269 0.263cvIF

ci 0.806 0.299ct

ahcvIFE

Page 14: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Hierarchical cluster analysis

cvIF

cvIFE

cvmo

Page 15: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

-36 -30 -24 -18 -12 -6 -1 +1 +6+12

15

20

25

30

35

40

45

50

purely CAMR

CMR

Time before (-) and after (+) biopsy (Bx) (months)

Mea

n eG

FR v

alue

(ml/m

in/1

.73

m2)

Mean eGFR values in purely CAMR and CMR

Page 16: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Postbiopsy therapy

Therapy

Purely CAMR CMR

CAMR (n=35)

Chronic active TMR (n=12)

Chronic active TMR and acute ISR

(n=4)

Acute ISR (n=10)

Steroid pulse 5 5 4 10

Intensification of maintenance

immunosuppression8 6 1 0

Anti-thymocyte globulin 0 0 2 0

Plasmapheresis 0 0 2 0

Left untreated 22 2 0 0

Page 17: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Mean graft survival in purely CAMR and CMR groups

Purely CAMR

CMR

p=0.011

50 vs 22 months

Page 18: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Multivariable Cox regression of morphological variables

g

ptc

ci ah

cvmo

ct

i

cg ptcml

HLA-DR

C4d

t

cvIF

cvIFECNI-tox.

Page 19: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

Discussion

I. CMR was frequent in our series (43%)II. Chronic active arteritis appeared to be T-

cell-relateda. T-cell predominance in 14/16 casesb. Clustered with TMR lesions

C. Lefaucheur et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 2013; 381: 313-319.

Page 20: D. Dobi,   Zs . Bodó, É. Kemény, K.  Boda a , P.  Szenohradszky b , E.  Szederkényi b , B. Iványi

III. CMR was characterized by poorer allograft survival and more reduced allograft function than purely chronic AMR if chronic active arteritis was part of the TMR component

IV. The immunohistochemical profiling of chronic active arteritis is recommended